Literature DB >> 12929709

It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.

George S Yacoubian1, Cynthia Boyle, Christine A Harding, Elizabeth A Loftus.   

Abstract

The use of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") appears to be increasing worldwide, with "rave" attendees being one high-risk population. To date, however, only one study has collected ecstasy use information from rave attendees in the United States. To address this limitation, we collected self-report drug use information from 70 adult "club rave" attendees within the Baltimore-Washington corridor in April and May 2002. Data collection was scheduled between 12 A.M. and 5 A.M. Participation rates were high, with 85 percent of the club rave attendees completing the interview. Eighty-six percent of the respondents reported lifetime ecstasy use, 51 percent reported 30-day use, and 30 percent reported using ecstasy within the two days preceding the interview. While past-year ecstasy users were comparable to non-users with respect to a host of demographic and drug use variables, non-ecstasy users were significantly more likely than past-year users to perceive risks associated with the regular use of alcohol and ecstasy. Not surprisingly, non-ecstasy users were significantly more likely than past-year users to perceive harmful long-term physical and psychological effects associated with ecstasy ingestion. These findings suggest that rave attendees may be an important population for ecstasy-related prevention efforts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12929709     DOI: 10.2190/RJX5-WRA6-BNG5-Q2TY

Source DB:  PubMed          Journal:  J Drug Educ        ISSN: 0047-2379


  13 in total

1.  Impulsivity and executive functions in polysubstance-using rave attenders.

Authors:  Antonio Verdejo-García; María Del Mar Sánchez-Fernández; Luisa María Alonso-Maroto; Fermín Fernández-Calderón; Jose C Perales; Oscar Lozano; Miguel Pérez-García
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

2.  Drug and alcohol-impaired driving among electronic music dance event attendees.

Authors:  Debra Furr-Holden; Robert B Voas; Tara Kelley-Baker; Brenda Miller
Journal:  Drug Alcohol Depend       Date:  2006-05-03       Impact factor: 4.492

Review 3.  A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).

Authors:  Brian J Piper
Journal:  Neurotoxicol Teratol       Date:  2006-10-20       Impact factor: 3.763

4.  MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study.

Authors:  Andrew C Parrott; Amy Gibbs; Andrew B Scholey; Rebecca King; Katherine Owens; Phil Swann; Ed Ogden; Con Stough
Journal:  Psychopharmacology (Berl)       Date:  2011-02-12       Impact factor: 4.530

5.  Perceived risk associated with ecstasy use: a latent class analysis approach.

Authors:  S S Martins; R G Carlson; P K Alexandre; R S Falck
Journal:  Addict Behav       Date:  2011-01-20       Impact factor: 3.913

6.  GENDER, SEXUALITY, AND ETHNICITY AS FACTORS OF CLUB DRUG USE AMONG ASIAN AMERICANS.

Authors:  A Fazio; K Joe-Laidler; M Moloney; G Hunt
Journal:  J Drug Issues       Date:  2010-03

7.  A Critical Assessment of Bias in Survey Studies Using Location-Based Sampling to Recruit Patrons in Bars.

Authors:  Christopher Morrison; Juliet P Lee; Paul J Gruenewald; Miesha Marzell
Journal:  Subst Use Misuse       Date:  2015       Impact factor: 2.164

8.  Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression.

Authors:  Kit Sang Leung; Arbi Ben Abdallah; Jan Copeland; Linda B Cottler
Journal:  Addict Behav       Date:  2009-10-18       Impact factor: 3.913

9.  During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study.

Authors:  Derek G Moore; John D Turner; Andrew C Parrott; Julia E Goodwin; Sarah E Fulton; Meeyoung O Min; Helen C Fox; Fleur M B Braddick; Emma L Axelsson; Stephanie Lynch; Helena Ribeiro; Caroline J Frostick; Lynn T Singer
Journal:  J Psychopharmacol       Date:  2009-11-25       Impact factor: 4.153

Review 10.  Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.

Authors:  Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.